Download the Free Unbound MEDLINE PubMed App to your smartphone or tablet.
Available for iPhone, iPad, iPod touch, and Android:
Available for Mac and Windows Desktops and laptops:
- Palonosetron in combination with 1-day versus 3-day dexamethasone for prevention of nausea and vomiting following paclitaxel and carboplatin in patients with gynecologic cancers: A randomized, multicenter, phase-II trial. [JOURNAL ARTICLE]
- J Obstet Gynaecol Res 2015 Jul 21.
- Palonosetron versus granisetron in combination with aprepitant for the prevention of chemotherapy-induced nausea and vomiting in a population with gynecologic malignancy treated with moderately emetic chemotherapy. [JOURNAL ARTICLE]
- J Gynecol Oncol 2015 Jul 20.
- Efficacy and safety of olanzapine combined with aprepitant, palonosetron, and dexamethasone for preventing nausea and vomiting induced by cisplatin-based chemotherapy in gynecological cancer: KCOG-G1301 phase II trial. [JOURNAL ARTICLE]
- Support Care Cancer 2015 Jul 1.
- The impact of 5-hydroxytryptamine-receptor antagonists on chemotherapy treatment adherence, treatment delay, and nausea and vomiting. [Journal Article]
- Cancer Manag Res 2015.:175-88.
- Effect of single doses of IV palonosetron, up to 2.25 mg, on the QTc interval duration: a double-blind, randomized, parallel group study in healthy volunteers. [JOURNAL ARTICLE]
- Support Care Cancer 2015 Jun 26.
- Prevention and management of chemotherapy-induced nausea and vomiting. [Journal Article]
- Int J Palliat Nurs 2015 May 2; 21(5):216-24.
- Palonosetron with aprepitant plus dexamethasone to prevent chemotherapy-induced nausea and vomiting during gemcitabine/cisplatin in urothelial cancer patients. [JOURNAL ARTICLE]
- Int J Urol 2015 Jun 18.
- Comparative efficacy of serotonin (5-HT3) receptor antagonists in patients undergoing surgery: a systematic review and network meta-analysis. [Journal Article, Research Support, Non-U.S. Gov't]
- BMC Med 2015.:136.
- The effect of combination treatment using palonosetron and dexamethasone for the prevention of postoperative nausea and vomiting versus dexamethasone alone in women receiving intravenous patient-controlled analgesia. [Journal Article]
- Korean J Anesthesiol 2015 Jun; 68(3):267-73.